Understand the problem first: Read the question carefully, identify inputs, outputs, and constraints before writing any code to avoid confusion and mistakes. Break complex problems into small steps: ...

Artificial intelligence (AI) models usually learn programming languages by absorbing huge amounts of training data. But what happens when the language is rare and the examples are scarce? A new study ...

TORONTO and DAEJEON, South Korea, March 11, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, has partnered with the Electronics and ...

An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...

Abstract: This paper presents a task planning and resource scheduling algorithm based on a regret-driven greedy strategy and dynamic programming. The algorithm addresses key challenges such as ...

AI is beginning to make inroads into designing and managing programmable logic, where it can be used to simplify and speed up portions of the design process. FPGAs and DSPs are st ...

Sam Crenshaw is a veteran sports reporter and TV sports anchor on the CBS News Atlanta team. Sam is known in the Atlanta community for his knowledge of local athletes and teams as well as his passion ...

Further Israeli troop withdrawals in Gaza tied to Hamas giving up weapons US and Trump's Board of Peace to pressure Hamas to disarm Palestinian militant group says it has not seen detailed or concrete ...

With the wide application of UAVs in modern operations, efficient cooperative task assignment of heterogeneous UAVs under complex constraints has become crucial for enhancing mission success rates.

Anthropic is launching Cowork for Claude as a research preview. It's built upon Claude Code and can automate complex tasks. However, it comes with security risks. Anthropic is testing a new feature ...

Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial planned to start in the first quarter of 2026 Jay Hagan joins as Chief Executive Officer ...